Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (1,799,043)	$ (1,216,329)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,105,420	778,875
Bad debt expense	65,000	36,000
Inventory obsolescence	95,235	30,511
Share-based compensation	803,386	597,305
Noncash lease expense	100,517	76,545
Accretion of finance liabilities	58,834
Amortization of debt issuance costs	3,083
Change in fair value of earnout liabilities	(65,678)	(452,687)
Changes in operating assets and liabilities:
Accounts receivable, net	(735,490)	352,102
Accounts receivable – related parties	(14,602)	74,602
Inventory, net	393,148	86,785
Prepaid and other assets	(303,182)	(361,719)
Accounts payable	(732,266)	405,360
Accounts payable – related parties	9,311	(10,747)
Accrued royalties and expenses	300,574	(112,774)
Accrued bonuses and commissions	(783,390)	(1,949,325)
Operating lease liabilities	(95,227)	(75,817)
Net cash used in operating activities	(1,594,370)	(1,741,313)
Cash flows from investing activities:
Purchases of property and equipment	(65,818)	(27,705)
Proceeds from disposal of property and equipment		650
Net cash used in investing activities	(65,818)	(27,055)
Cash flows from financing activities:
Equity offering net proceeds		751,752
Net settlement of equity-based awards	(580,794)	(655,942)
Cash payment of finance and earnout liabilities	(78,000)
Net cash provided by (used in) financing activities	(658,794)	95,810
Net decrease in cash	(2,318,982)	(1,672,558)
Cash, beginning of period	5,147,216	8,958,995
Cash, end of period	2,828,234	7,286,437
Cash paid during the period for:
Interest	205,591	6
Supplemental noncash investing and financing activities:
Equity offering accrued proceeds		282,010
Right of use assets obtained in exchange for lease obligations		$ 1,369,164